AK112
Drug timelines are a Plus or Pro feature.
56 regulatory and trial events tracked for AK112, covering 2024-05-22 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]